NASDAQ: MNMDMind Medicine Inc Stock Ownership - Who owns Mind Medicine?
Insider buying vs selling
Have Mind Medicine Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert Barrow | Chief Executive Officer | 2025-09-25 | 25,797 | $9.77 | $252.04kSell |
| Daniel Karlin | Chief Medical Officer | 2025-09-25 | 7,704 | $9.77 | $75.27kSell |
| Mark Sullivan | Chief Legal Officer | 2025-09-25 | 11,278 | $9.77 | $110.19kSell |
| Daniel Karlin | Chief Medical Officer | 2025-06-25 | 7,848 | $6.80 | $53.37kSell |
| Robert Barrow | Chief Executive Officer | 2025-06-25 | 26,491 | $6.80 | $180.14kSell |
| Mark Sullivan | Chief Legal Officer | 2025-06-25 | 11,491 | $6.80 | $78.14kSell |
| Daniel Karlin | Chief Medical Officer | 2025-03-25 | 6,836 | $6.74 | $46.07kSell |
| Carrie Liao | Chief Accounting Officer | 2025-03-25 | 2,347 | $6.74 | $15.82kSell |
| Mark Sullivan | Chief Legal Officer | 2025-03-25 | 6,576 | $6.74 | $44.32kSell |
| Robert Barrow | Chief Executive Officer | 2025-03-25 | 21,208 | $6.74 | $142.94kSell |
MNMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MNMD insiders and whales buy or sell their stock.
MNMD Shareholders
What type of owners hold Mind Medicine Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stephen L. Hurst | 41.34% | 40,722,778 | $473.61M | Insider |
| Blackrock Inc | 6.03% | 5,935,557 | $69.03M | Institution |
| Vanguard Group Inc | 2.04% | 2,012,874 | $23.41M | Institution |
| Geode Capital Management LLC | 1.85% | 1,824,701 | $21.22M | Institution |
| Cynthia W. Hu | 1.22% | 1,200,000 | $13.96M | Insider |
| Robert Barrow | 0.82% | 804,268 | $9.35M | Insider |
| Charles Schwab Investment Management Inc | 0.64% | 633,702 | $7.37M | Institution |
| Daniel Karlin | 0.44% | 430,625 | $5.01M | Insider |
| Dan Karlin | 0.34% | 338,013 | $3.93M | Insider |
| Mark Sullivan | 0.30% | 293,852 | $3.42M | Insider |
MNMD vs Biotech Stocks
Mind Medicine Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.